Revised SPC: Mekinist (trametinib) capsules

SPC now reports that sarcoidosis is an uncommon potential adverse effect of trametinib and dabrafenib combination therapy, though in the majority of reported cases treatment was maintained. It is important not to misinterpret sarcoidosis as disease progression.

Source:

electronic Medicines compendium